Pages that link to "Q28250437"
Jump to navigation
Jump to search
The following pages link to Opioid metabolism (Q28250437):
Displaying 50 items.
- From Individualized Treatment of Sickle Cell Pain to Precision Medicine: A 40-Year Journey (Q26747771) (← links)
- Drug-drug interactions during antiviral therapy for chronic hepatitis C (Q26864887) (← links)
- Laboratory testing for prescription opioids (Q27015926) (← links)
- The Role of Opioid Analgesics in Geriatric Pain Management (Q28073839) (← links)
- Adverse drug interactions (Q28307440) (← links)
- 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma (Q28392783) (← links)
- 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma (Q28394414) (← links)
- Pain management in the cirrhotic patient: the clinical challenge (Q30494286) (← links)
- Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. (Q33753044) (← links)
- Pain management: Part 1: Managing acute and postoperative dental pain (Q33918219) (← links)
- Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for Pharmacists (Q33924852) (← links)
- Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential. (Q34143327) (← links)
- Opioid rotation in clinical practice (Q34305249) (← links)
- The management of chronic pain in important patient subgroups (Q34326675) (← links)
- Review article: prescribing medications in patients with cirrhosis - a practical guide (Q34342554) (← links)
- Toward a systematic approach to opioid rotation (Q34394425) (← links)
- Prescription of opioids for opioid-naive medical inpatients (Q34427847) (← links)
- Combining opioid and adrenergic mechanisms for chronic pain (Q34434307) (← links)
- Drug testing for newborn exposure to illicit substances in pregnancy: pitfalls and pearls (Q35113865) (← links)
- Postoperative pain management in patients with chronic kidney disease (Q35157828) (← links)
- Opioids for chronic noncancer pain in the elderly: an osteoarthritis case (Q35162416) (← links)
- Individual Differences in Morphine and Butorphanol Analgesia: A Laboratory Pain Study (Q35163746) (← links)
- Prevention of postoperative nausea and vomiting with a subhypnotic dose of Propofol in patients undergoing lower abdominal surgery: A prospective, randomized, double-blind study (Q35172441) (← links)
- Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats (Q35174033) (← links)
- Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus (Q35358687) (← links)
- Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release (Q35596682) (← links)
- Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy. (Q35622561) (← links)
- Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis (Q35694513) (← links)
- Pharmacology of nonsteroidal antiinflammatory drugs and opioids (Q35882922) (← links)
- Opioid-independent mechanisms supporting offset analgesia and temporal sharpening of nociceptive information (Q35981314) (← links)
- Variable Patterns of Continuous Morphine Infusions at End of Life (Q36006860) (← links)
- In vitro metabolism of specific CYP2D and CYP3A opioid substrates using rat liver S9 fractions and mass spectrometry reveal a severe metabolic impairment with increasing age. (Q36070671) (← links)
- Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers (Q36424264) (← links)
- The Changing Use of Intravenous Opioids in an Emergency Department (Q36435855) (← links)
- Update on prescription extended-release opioids and appropriate patient selection (Q37053718) (← links)
- Drug-Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers (Q37067118) (← links)
- Options for treating postherpetic neuralgia in the medically complicated patient (Q37120711) (← links)
- Hepatic resection is associated with reduced postoperative opioid requirement (Q37229012) (← links)
- Oxycodone-induced conditioned place preference and sensitization of locomotor activity in adolescent and adult mice (Q37248900) (← links)
- Research priorities in geriatric palliative care: nonpain symptoms (Q37280693) (← links)
- A service improvement project to review prescribing information provided by general practitioners for new referrals to a UK National Health Service hospital pain clinic: potential implications of CYP2D6 enzyme inhibition (Q37403673) (← links)
- Urine toxicology testing in chronic pain management (Q37566070) (← links)
- Implications of opioid analgesia for medically complicated patients (Q37744893) (← links)
- Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute pain (Q37781810) (← links)
- Opioid Therapy for Osteoarthritis and Chronic Low Back Pain (Q37810414) (← links)
- Pain in malignant hematology (Q37842353) (← links)
- The use of opioids for dyspnea in advanced disease (Q37950060) (← links)
- Management of Chronic Noncancer Pain in Depressed Patients (Q37929505) (← links)
- Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl (Q37950117) (← links)
- A review of opioids for in-hospital pain management (Q37992490) (← links)